GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2065.40-14.4 (-0.69 %)
PREV CLOSE ( ) 2079.80
OPEN PRICE ( ) 2080.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14837
TODAY'S LOW / HIGH ( )2039.75 2118.00
52 WK LOW / HIGH ( )1228 2649.95
NSE2065.60-11.65 (-0.56 %)
PREV CLOSE( ) 2077.25
OPEN PRICE ( ) 2078.00
BID PRICE (QTY) 2065.60 (111)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 190449
TODAY'S LOW / HIGH( ) 2041.00 2118.00
52 WK LOW / HIGH ( )1227 2524
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.